Literature DB >> 24863149

Decreased γ-aminobutyric acid levels in the parietal region of patients with Alzheimer's disease.

Xue Bai1, Richard A E Edden, Fei Gao, Guangbin Wang, Lebin Wu, Bin Zhao, Minzhong Wang, Queenie Chan, Weibo Chen, Peter B Barker.   

Abstract

PURPOSE: To determine whether there are in vivo differences of γ-aminobutyric acid (GABA) levels in frontal and parietal regions of Alzheimer's disease (AD) patients, compared with healthy controls using magnetic resonance spectroscopy ((1) H-MRS).
MATERIALS AND METHODS: Fifteen AD patients and fifteen age- and gender-matched healthy controls underwent (1) H-MRS of the frontal and parietal lobes using the "MEGA-Point Resolved Spectroscopy Sequence" (MEGA-PRESS) technique, and cognitive levels of subjects were evaluated using Mini-Mental State Examination (MMSE) tests. MRS data were processed using the Gannet program. Because the signal detected by MEGA-PRESS includes contributions from GABA, macromolecules and homocarnosine, it is labeled as "GABA+" rather than GABA. Differences of GABA+/Cr ratios between AD patients and controls were tested using covariance analysis, adjusting for gray matter fraction. The relationship between GABA+/Cr and MMSE scores was also analyzed.
RESULTS: Significant lower GABA+/Cr ratios were found in the parietal region of AD patients compared with controls (P = 0.041). In AD patients, no significant correlations between GABA+/Cr and MMSE scores were found in either the frontal (r = -0.164; P = 0.558) or parietal regions (r = 0.025; P = 0.929).
CONCLUSION: Decreased GABA+/Cr levels were present in the parietal region of patients with AD in vivo, suggesting that abnormalities of the GABAergic system may be present in the pathogenesis of AD.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  1H-MRS; Alzheimer's disease; GABA; MEGA-PRESS; MMSE

Mesh:

Substances:

Year:  2014        PMID: 24863149      PMCID: PMC5512098          DOI: 10.1002/jmri.24665

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  37 in total

1.  In vivo detection of gray and white matter differences in GABA concentration in the human brain.

Authors:  In-Young Choi; Sang-Pil Lee; Hellmut Merkle; Jun Shen
Journal:  Neuroimage       Date:  2006-08-01       Impact factor: 6.556

2.  Cognitive functioning and GABAA/benzodiazepine receptor binding in schizophrenia: a 123I-iomazenil SPET study.

Authors:  S Ball; G F Busatto; A S David; S H Jones; D R Hemsley; L S Pilowsky; D C Costa; P J Ell; R W Kerwin
Journal:  Biol Psychiatry       Date:  1998-01-15       Impact factor: 13.382

3.  Proton and phosphorus magnetic resonance spectroscopy of a mouse model of Alzheimer's disease.

Authors:  Vladimír Mlynárik; Matthias Cacquevel; Lili Sun-Reimer; Sharon Janssens; Cristina Cudalbu; Hongxia Lei; Bernard L Schneider; Patrick Aebischer; Rolf Gruetter
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

4.  Medial temporal lobe atrophy relates to executive dysfunction in Alzheimer's disease.

Authors:  Joukje M Oosterman; Saskia Oosterveld; Marcel G Olde Rikkert; Jurgen A Claassen; Roy P C Kessels
Journal:  Int Psychogeriatr       Date:  2012-04-25       Impact factor: 3.878

5.  GABA concentration is reduced in visual cortex in schizophrenia and correlates with orientation-specific surround suppression.

Authors:  Jong H Yoon; Richard J Maddock; Ariel Rokem; Michael A Silver; Michael J Minzenberg; J Daniel Ragland; Cameron S Carter
Journal:  J Neurosci       Date:  2010-03-10       Impact factor: 6.167

6.  Differences between GABA levels in Alzheimer's disease and Down syndrome with Alzheimer-like neuropathology.

Authors:  R Seidl; N Cairns; N Singewald; S T Kaehler; G Lubec
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2001-02       Impact factor: 3.000

7.  Gamma-aminobutyric acid concentration in brain tissue at two stages of Alzheimer's disease.

Authors:  S L Lowe; P T Francis; A W Procter; A M Palmer; A N Davison; D M Bowen
Journal:  Brain       Date:  1988-08       Impact factor: 13.501

8.  A postmortem study of amino acid neurotransmitters in Alzheimer's disease.

Authors:  D W Ellison; M F Beal; M F Mazurek; E D Bird; J B Martin
Journal:  Ann Neurol       Date:  1986-11       Impact factor: 10.422

9.  [Developmental disorders in the fourth edition of the American classification: diagnostic and statistical manual of mental disorders (DSM IV -- optional book)].

Authors:  A Gmitrowicz; A Kucharska
Journal:  Psychiatr Pol       Date:  1994 Sep-Oct       Impact factor: 1.657

10.  Magnetic resonance spectroscopy in Alzheimer's disease.

Authors:  Jonathan Graff-Radford; Kejal Kantarci
Journal:  Neuropsychiatr Dis Treat       Date:  2013-05-16       Impact factor: 2.570

View more
  28 in total

1.  Diurnal changes in glutamate + glutamine levels of healthy young adults assessed by proton magnetic resonance spectroscopy.

Authors:  Carina Volk; Valeria Jaramillo; Renato Merki; Ruth O'Gorman Tuura; Reto Huber
Journal:  Hum Brain Mapp       Date:  2018-06-08       Impact factor: 5.038

2.  Reproducibility of macromolecule suppressed GABA measurement using motion and shim navigated MEGA-SPECIAL with LCModel, jMRUI and GANNET.

Authors:  Muhammad G Saleh; Jamie Near; Alqadafi Alhamud; Frances Robertson; André J W van der Kouwe; Ernesta M Meintjes
Journal:  MAGMA       Date:  2016-07-08       Impact factor: 2.310

3.  Hippocampal GABA levels correlate with retrieval performance in an associative learning paradigm.

Authors:  Benjamin Spurny; Rene Seiger; Philipp Moser; Thomas Vanicek; Murray B Reed; Eva Heckova; Paul Michenthaler; Alim Basaran; Gregor Gryglewski; Manfred Klöbl; Siegfried Trattnig; Siegfried Kasper; Wolfgang Bogner; Rupert Lanzenberger
Journal:  Neuroimage       Date:  2019-10-10       Impact factor: 6.556

4.  GABA-induced motor improvement following acute cerebral infarction.

Authors:  Qingmei Chen; Jun Ke; Xiuying Cai; Haiwei Sun; Zhiguo Chen; Li Li; Min Su; Qi Fang
Journal:  Am J Transl Res       Date:  2020-12-15       Impact factor: 4.060

5.  Correcting miR92a-vGAT-Mediated GABAergic Dysfunctions Rescues Human Tau-Induced Anxiety in Mice.

Authors:  Xiaoguang Li; Zhihao Wang; Lu Tan; Yali Wang; Chengbiao Lu; Rongxiang Chen; Shujuan Zhang; Yuan Gao; Yanchao Liu; Yaling Yin; Xinghua Liu; Enjie Liu; Ying Yang; Yu Hu; Zhipeng Xu; Fuqiang Xu; Jie Wang; Gong-Ping Liu; Jian-Zhi Wang
Journal:  Mol Ther       Date:  2017-01-04       Impact factor: 11.454

6.  Atlas-based GABA mapping with 3D MEGA-MRSI: Cross-correlation to single-voxel MRS.

Authors:  Ruoyun E Ma; James B Murdoch; Wolfgang Bogner; Ovidiu Andronesi; Ulrike Dydak
Journal:  NMR Biomed       Date:  2020-02-20       Impact factor: 4.044

7.  GABA quantitation using MEGA-PRESS: Regional and hemispheric differences.

Authors:  Monika Grewal; Aroma Dabas; Sumiti Saharan; Peter B Barker; Richard A E Edden; Pravat K Mandal
Journal:  J Magn Reson Imaging       Date:  2016-06-05       Impact factor: 4.813

8.  GABA levels and TSPO expression in people at clinical high risk for psychosis and healthy volunteers: a PET-MRS study.

Authors:  Tania Da Silva; Sina Hafizi; Pablo M Rusjan; Sylvain Houle; Alan A Wilson; Ivana Prce; Napapon Sailasuta; Romina Mizrahi
Journal:  J Psychiatry Neurosci       Date:  2019-03-01       Impact factor: 6.186

9.  Whole-slice mapping of GABA and GABA+ at 7T via adiabatic MEGA-editing, real-time instability correction, and concentric circle readout.

Authors:  Philipp Moser; Lukas Hingerl; Bernhard Strasser; Michal Považan; Gilbert Hangel; Ovidiu C Andronesi; Andre van der Kouwe; Stephan Gruber; Siegfried Trattnig; Wolfgang Bogner
Journal:  Neuroimage       Date:  2018-09-19       Impact factor: 6.556

10.  Prefrontal GABA Levels Correlate with Memory in Older Adults at High Risk for Alzheimer's Disease.

Authors:  Geetanjali Murari; Darren Ri-Sheng Liang; Aliya Ali; Frankie Chan; Mirjam Mulder-Heijstra; Nicolaas Paul L G Verhoeff; Nathan Herrmann; J Jean Chen; Linda Mah
Journal:  Cereb Cortex Commun       Date:  2020-06-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.